In a bilateral GBM mouse model, it was demonstrated that local RT combined with anti-PD-L1 treatment caused decreased viability of the contralateral non-irradiated GBM lesion with resulting increased overall survival compared to RT or anti-PD-L1 monotherapy alone (227). The gene discussed is CD274; the disease is glioblastoma.